SLOT: Full Definition
What is Wegovy?
Wegovy is the brand name for higher-dose injectable Semaglutide, FDA-approved specifically for chronic weight management. It is the same active ingredient as Ozempic (the lower-dose version approved for type 2 diabetes) and Rybelsus (oral semaglutide for diabetes). Aliases include branded semaglutide for weight loss.
Wegovy is approved for adults with a BMI ≥ 30, or BMI ≥ 27 with at least one weight-related condition such as hypertension, type 2 diabetes, dyslipidemia, [pcos]-related metabolic dysfunction, or obstructive sleep apnea. It is also approved for adolescents 12 and older with obesity, and increasingly studied for cardiovascular risk reduction.
How does Wegovy work?
Wegovy mimics the natural gut hormone GLP-1, which the body releases after eating. By binding to GLP-1 receptors throughout the body, it:
- Slows gastric emptying so meals stay in the stomach longer.
- Acts on appetite centers in the brain to quiet food noise and reduce hunger.
- Triggers insulin release after meals and suppresses glucagon, improving blood sugar control.
- Reduces reward-driven snacking and cravings.
Clinical trials of Wegovy at the full 2.4 mg weekly dose have shown average weight loss of roughly 15% of body weight over 68 weeks — substantially more than older weight-loss medications. Cardiovascular outcome trials in patients with overweight and existing cardiovascular disease have shown a meaningful reduction in heart attack, stroke, and cardiovascular death.
When is it prescribed?
Wegovy is typically prescribed for:
- Adults with BMI ≥ 30, or BMI ≥ 27 with weight-related conditions.
- Adolescents 12+ with obesity defined by BMI percentile.
- Patients with cardiovascular disease who would benefit from both weight loss and cardiovascular risk reduction.
- Increasingly, women with Insulin Resistance, PCOS, or post-menopausal weight gain when other approaches have plateaued.
It is started at 0.25 mg weekly and titrated up every four weeks to 2.4 mg, the maintenance dose.
Patient considerations
The most common side effects are gastrointestinal — nausea, constipation, diarrhea, reflux, bloating, and early fullness — usually worst during dose escalation. Less common but serious risks include pancreatitis, gallstones, gastroparesis, and acute kidney injury (often from dehydration during GI symptoms).
Wegovy carries a black-box warning for thyroid C-cell tumors, including medullary thyroid carcinoma, based on rodent data. It is not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome. It is also contraindicated in pregnancy and should be discontinued at least two months before a planned pregnancy.
The single most important issue we see clinically is muscle loss. Roughly one-third of weight lost on GLP-1s is lean mass — including muscle and bone. That has long-term consequences for metabolism, strength, and weight maintenance. Protecting muscle requires adequate protein (typically 1.2-1.6 g per kg of body weight per day) and resistance training at least two to three times per week. These are non-negotiable, not optional.
At Modern Thyroid Clinic, Wegovy is viewed as one tool in a comprehensive plan. The women who do best pair it with thyroid optimization, nutrient repletion, sleep work, stress regulation, and strength training — and they have a clear plan for what life looks like during, and after, the medication.
Common symptoms
Common questions
How is Wegovy different from Ozempic?
Wegovy and Ozempic both contain semaglutide — the same active ingredient. Wegovy is FDA-approved specifically for weight loss at doses up to 2.4 mg weekly. Ozempic is approved for type 2 diabetes at doses up to 2 mg weekly. In practice, many patients are prescribed one or the other based on indication, insurance coverage, and supply availability. Wegovy's higher maintenance dose is what drives its larger average weight-loss results in clinical trials, around 15% versus 5-10% on standard Ozempic doses.
Do I have to stay on Wegovy forever?
Obesity is a chronic condition, and most patients regain a significant portion of lost weight when Wegovy is stopped — usually because appetite returns to baseline. That said, "forever" is not the only option. Some patients taper to a lower maintenance dose; others stop with a structured plan that includes intensive nutrition, strength training, thyroid and hormone optimization, and behavioral support. The right answer depends on goals, side effects, cost, and how your body responds. This is a long-term clinical decision, not a one-time prescription.
What can I do to limit muscle loss on Wegovy?
Two things matter most. First, eat enough protein — typically 1.2 to 1.6 grams per kilogram of body weight per day, distributed across meals. Most women on Wegovy fall well short of this because they're simply less hungry. Second, do resistance training at least two to three times a week, focusing on compound movements (squats, deadlifts, presses, rows). Cardio alone won't protect muscle. Adequate sleep, vitamin D, creatine, and addressing low ferritin or thyroid issues also support lean mass during weight loss.
Think you might be dealing with this?
Talk to a Modern Thyroid Clinic specialist about your symptoms, labs, and next steps.
Book a Discovery CallThis content is for educational purposes only and is not medical advice. Consult a licensed clinician for diagnosis and treatment. Content on this page does not create a doctor-patient relationship with Modern Thyroid Clinic.